---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-22-000096"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:44:11.832859+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# iBio closes $3.5M underwritten public offering of common stock and warrants

## Summary
- Offering includes 3,365,385 shares (or pre-funded warrants) plus Series A and B warrants at $1.04 per share.
- Series A warrants expire 5 years; Series B warrants expire 24 months from issuance, both immediately exercisable.
- Gross proceeds ~$3.5M; net proceeds for operating costs, R&D, working capital, and debt payments.
- Underwriter H.C. Wainwright partially exercised option for additional warrants to buy up to 1,009,614 shares.
- Shareholder votes at Dec 8 annual meeting: elected directors Armstrong and Kropotova, ratified auditor, approved say-on-pay.

## SEC filing metadata
- accession: 0001420720-22-000096
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/ibio-20221208x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-22-000096
- JSON: https://secwatch.observer/filing/0001420720-22-000096.json
- Plain text: https://secwatch.observer/filing/0001420720-22-000096.txt

## Key facts
- Shareholder Votes
  iBio, Inc. shareholders approved Advisory vote on executive compensation at the 2022-12-08 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Proposal 3 The stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers ("say-on-pay"), as disclosed in the Definitive Proxy Statement. The results of the voting for this approved proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 780,830 537,904 28,727 2,552,791
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm
- Shareholder Votes
  iBio, Inc. shareholders approved Election of Class II directors at the 2022-12-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Proposal 1 The following two (2) nominees named as Class II directors of the Company’s Board of Directors, each to serve a three-year term expiring at the 2025 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified, were elected with the following votes: Name of Director Votes For Withheld Broker Non-Votes 1. Dr. Linda W. Armstrong ​ 1,051,212 ​ 296,249 ​ 0 2. Dr. Alexandra Kropotova 1,027,547 319,914 0 ​
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm
- Shareholder Votes
  iBio, Inc. shareholders approved Ratification of CohnReznick LLP as independent registered public accounting firm for the year ending June 30, 2022 at the 2022-12-08 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-12-08
  source text: Proposal 2 The stockholders ratified the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the year ending June 30, 2022 based on the votes set forth below: Votes For Votes Against Abstentions Broker Non-Votes 3,226,366 607,132 66,754 0 ​
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000096/0001420720-22-000096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.